aTYR PHARMA INC Annual Share-based Payment Arrangement, Expense in USD from 2013 to 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary: aTYR PHARMA INC quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2013 to 2023.
aTYR PHARMA INC Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $727K, a 10.5% increase year-over-year.
aTYR PHARMA INC Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $2.79M, a 11.7% increase year-over-year.
aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2023 was $2.6M, a 20.7% increase from 2022.
aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2022 was $2.15M, a 33.5% increase from 2021.
aTYR PHARMA INC annual Share-based Payment Arrangement, Expense for 2021 was $1.61M, a 10.2% increase from 2020.

Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)

Share-based Payment Arrangement, Expense, Annual (USD)

Share-based Payment Arrangement, Expense, YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2023	$2.6M	+$446K	+20.7%	Jan 1, 2023	Dec 31, 2023	10-K	2024-03-14
2022	$2.15M	+$540K	+33.5%	Jan 1, 2022	Dec 31, 2022	10-K	2024-03-14
2021	$1.61M	+$149K	+10.2%	Jan 1, 2021	Dec 31, 2021	10-K	2024-03-14
2020	$1.47M	-$318K	-17.8%	Jan 1, 2020	Dec 31, 2020	10-K	2023-03-14
2019	$1.78M	-$1.65M	-48%	Jan 1, 2019	Dec 31, 2019	10-K	2022-03-15
2018	$3.43M	-$3.35M	-49.4%	Jan 1, 2018	Dec 31, 2018	10-K	2021-03-24
2017	$6.78M	+$1.76M	+34.9%	Jan 1, 2017	Dec 31, 2017	10-K	2020-03-26
2016	$5.03M	+$173K	+3.56%	Jan 1, 2016	Dec 31, 2016	10-K	2019-03-26
2015	$4.86M	+$3.07M	+171%	Jan 1, 2015	Dec 31, 2015	10-K	2018-03-20
2014	$1.79M	+$1.64M	+1055%	Jan 1, 2014	Dec 31, 2014	10-K	2017-03-16
2013	$155K			Jan 1, 2013	Dec 31, 2013	10-K	2016-03-30

* An asterisk sign (*) next to the value indicates that the value is likely invalid.